URGING THE HAWAII STATE DIRECTOR OF HEALTH TO ISSUE A STATEWIDE ORDER TO ALLOW FOR THE SALE AND PURCHASE OF NEBULIZED BUDESONIDE WITHOUT A PRESCRIPTION OR CONSULTATION WITH A HEALTHCARE PROVIDER.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 2 Sponsors

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber: House
Introduced: Mar 16, 2026
Last action: Mar 16, 2026 — Offered
Session: 2026
Momentum: 27 · Low

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 4%, measured from HI's completed sessions
Momentum -5 27/100 from the pace of recorded action
Time since last action -22 210 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.